Stock screener

TARA

Conviction 12HealthcareScan · Thu, Jun 25, 2026
TARA$3.99-0.99%
ResistanceSupportVol 14
63 bars
Vol MA14 677.15K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Protara Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.protaratx.com
Price3.99
Change-0.99%
Gap+1.61%
Rel volume0.81×
Avg volume644.36K
Avg $ vol2.63M
SMA 204.12
SMA 504.73
SMA 2005.28
Price vs 50-15.72%
Price vs 200-24.47%
MA stackbearish
50/200 cross
Supertrenddown · 4.54
RSI (14)41
MACD hist0.04
MACD crossbull · 4d
Stoch %K / %D46 / 46
ADX (14)26
+DI / −DI16 / 24
RSI divergence
MACD divergenceBullish
ATR %+6.20%
ADR %5.49%
52w high7.56
52w low2.78
From 52w high-47.22%
Above 52w low+43.53%
New 52w highNo
SqueezeOff
Bollinger width27.36%
%B0.39
Donchian pos31.65%
Donchian high4.80
Donchian low3.62
AVWAP (52w high)5.56
vs AVWAP high-28.27%
AVWAP (52w low)5.32
vs AVWAP low-25.06%
OBV trendDown
Chaikin MF (20)-0.41
Today vs 20d0.81×
Avg vol (14d)677.15K
Avg vol (20d)644.36K
Avg $ vol (20d)2.63M
Market cap224.25M
RS 3m (vs SPY)-31.82%
RS 6m (vs SPY)-31.27%
RS line new highNo
Trend template3/8
Technical rank14.7
1 week-1.97%
1 month-16.87%
3 months-24.86%
6 months-26.25%
1 year+30.39%
YTD-25.84%
P/E-3.90
P/B1.24
P/S76.07
P/FCF-3.97
EPS-1.34
Div yield
ROE-31.70%
ROA-29.93%
Debt/Eq0.00
Current15.69
EV/EBITDA-3.25
Gross margin
Net margin
Rev growth0.00%
EPS growth-28.80%
Price target
Target upside
Analyst rating
Institutional
Ent. value209.52M
Revenue2.95M
Net income-17.78M
Gross profit
Free cash flow-56.46M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out56.2M
Employees51
ListedFri, Jan 10, 2020
Free float45.86M
Float %88.8%
Short interest5.89M
Days to cover6.2d
Short volume57.0%
Squeeze score62 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction12 / 100
Pattern quality
Tech rank14.7 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance5.39
Support3.97
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TARA

All disclosures →
No recent disclosed trades by Congress in TARA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TARA · 1 buy

InsiderSideShares
BESHAR LUKE M
Director · Stock Option (Right to Buy) · 2026-06-15
Grant31K

SEC filings

EDGAR filings in TARA · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.